Patents by Inventor James W. Purcell

James W. Purcell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD19 ANTIBODY DRUG CONJUGATES
    Publication number: 20240100181
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 28, 2024
    Inventors: Chewei A. Chang, Ethan D. Emberley, Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • Anti-huLRRC15 antibody drug conjugates and methods for their use
    Patent number: 11045480
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: June 29, 2021
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20190105329
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20190105328
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20190099431
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 11, 2018
    Publication date: April 4, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • Anti-huLRRC15 antibody drug conjugates and methods for their use
    Patent number: 10195209
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: February 5, 2019
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Anti-huLRRC15 antibody drug conjugates and methods for their use
    Patent number: 10188660
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: January 29, 2019
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20170151343
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Inventors: Kurt C. GISH, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20170151344
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Inventors: Kurt C. GISH, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • System for making food products
    Patent number: 6611805
    Abstract: A system is disclosed for reducing costs associated with making a plurality of food products incompatible in a single food product-making facility by a plurality of food product makers. A plurality of discrete food product-making plants are provided configured for use by the plurality of food product makers. A common area facility includes facilities sharable by the plurality of food product makers using and occupying the plurality of food product making plants. The plurality of food product making plants and common area facility are operated cooperatively by sharing use and costs associated with use of the common area facility by and among the plurality of food product makers.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: August 26, 2003
    Assignee: Specialty Cheese Company, Inc.
    Inventors: Paul Scharfman, James W. Purcell, Matthew D. Smith